Support the news

Genzyme V. Sanofi... Finis! 05:37
Download

Play
This article is more than 8 years old.
Genzyme’s headquarters in Cambridge (Stottyboombotty/Flickr)
Genzyme’s headquarters in Cambridge (Stottyboombotty/Flickr)

Cambridge biotech giant Genzyme has finally agreed to be purchased by French pharmaceutical company Sanofi-Aventis following nine months of negotiations. The price tag: $20 billion.

The future of Genzyme's 4,500 Massachusetts employees remains unclear, but there were hints about that Wednesday when the CEOs of both companies appeared together in public for the first time at Genzyme's headquarters in Kendall Square.

WBUR's Business and Technology Reporter Curt Nickisch fills us in.

This segment aired on February 16, 2011.

+Join the discussion
TwitterfacebookEmail

Support the news